Valacyclovir

Producers shown on SFDA

(Record date:31/08/2021）

Producers shown on EP

Not showing any

Producer:Changzhou Kony Pharmaceutical Co., Ltd.Founded in 1986, Shanghai Pharmaceutical Kangli (Changzhou) Pharmaceutical Co., Ltd. is a professional manufacturer of APIs and pharmaceutical intermediates. In 2012, it became a member enterprise of Shanghai Pharmaceutical Group, covering an area of 65000 square meters, with fixed assets of more than 50 million yuan and more than 240 employees, of which scientific and technological personnel account for 20%.

The company organizes production in strict accordance with GMP, has complete production and scientific research equipment, has a number of imported advanced testing equipment, has stable product quality, is exported to Southeast Asia and developed countries and regions, and enjoys a high reputation among customers at home and abroad.

Staff size:200-299 persons

Registered capital:RMB 14.94638 million

Producer:Yichang Tianren Pharmaceutical Co., Ltd., established in 2004, is a holding subsidiary of Yichang humanwell. The company is a high-tech enterprise engaged in the production and sales of chemical APIs and pharmaceutical intermediates.

The company has 4 chemical API production lines that have passed GMP certification, with an annual design production capacity of 120 tons of solid chemical API and 30 tons of liquid chemical API.

The company has more than 20 antiviral, local anesthesia and other products, and has carried out in-depth cooperation with many well-known pharmaceutical enterprises in China. The company's products have been sold to Japan, South Korea, Russia, Italy, Brazil, Egypt and other countries.

Staff size:100-199 persons

Registered capital:RMB 36.4286 million

Producer:Hubei Teyer Pharmaceutical Co., Ltd.was established in 2002. The factory covers an area of 16000 square meters. It has two GMP API synthesis workshops and one capsule and tablet workshop. Each workshop is equipped with an independent cleaning and refining area. Since its establishment in 2002, the enterprise has passed the SFDA inspection and certification of more than 10 API products and obtained the corresponding GMP certificate.

Staff size:About 50 peorsons

Registered capital:RMB 10 million

Producer:Fuan Pharmaceutical Group Chongqing Bosen Pharmaceutical Co., Ltd.was spun off from the group company to become a wholly-owned holding subsidiary on September 1, 2016. It has more than 600 employees, of which personnel with bachelor's degree or above account for 1 / 3 of the company, mainly engaged in the production and sales of APIs and preparations. At present, it mainly involves the fields of anti infection, anti-tumor, mental nervous system, cardiovascular and cerebrovascular system, digestive system, endocrine and metabolism, bone and muscle system and so on.

Staff size:600 persons

Registered capital:RMB 10 million

Producer:Shuanghe Pharmaceutical (Hainan) Co., Ltd. (formerly Hainan Sinochem United Pharmaceutical Industry Co., Ltd.) was established on April 7, 2004. It is a wholly-owned subsidiary of China Resources Shuanghe Pharmaceutical Co., Ltd. and a high-tech enterprise integrating production, R & D and marketing,

Staff size:200-299 persons

Registered capital:RMB 150 million

Chenlong pharmaceutical is committed to producing various high-quality, safe, efficient and complete varieties of APIs. After the project is completed and put into operation, it will achieve an annual output of 10 tons of heparin, 300 tons of alanyl glutamine (commonly known as dipeptide), 10 tons of adefovir dipivoxil, 3 tons of Ropivacaine Mesylate and 30 tons of hormones.

Staff size:200-299 persons

Registered capital:RMB 50 million

Producer:Hubei Yitai Pharmaceutical Co., Ltd. is a professional APIs  and food additives manufacturer. The company was founded in 2000 with a registered capital of 99.9 million RMB. After more than ten years of development, the total assets have reached to 400 million RMB. The total number of employees is 600. Among them, more than 30% are technicians from more than 10 provinces and cities. The company covers an area of 333000 m2, and the green area accounts for more than 35% of the total area.

Staff size:About 600 persons

Registered capital:RMB 106.566666 million 

Producer:Zhejiang Charioteer Pharmaceutical Co., Ltd. , founded in 1988, is a professional manufacturer of nucleoside antiviral series, anti-inflammatory and analgesic series and other APIs. It is committed to the sales and service in the international regulatory market. Its main products have passed the FDA certification of the United States and the cos certification of Europe. All products have obtained the national GMP certificate. In 2004, it passed ISO9001, ISO14001 and OHSAS18001 management system certification.

Staff size:About 1500 persons

Registered capital:RMB 84 million 375 thousand

Producer:Sichuan Kelun Pharmaceutical Co., Ltd., subordinate to Kelun group, was successfully listed on Shenzhen Stock Exchange in June 2010.

Sichuan Kelun Pharmaceutical Co., Ltd. is a core manufacturer and a leading large-capacity injection production base in China. The company has 568 varieties of 981 specifications of pharmaceutical products, including 124 varieties of 292 specifications of infusion products, 393 varieties of 636 specifications of other dosage forms of pharmaceutical products, 51 varieties of 53 specifications of API. In addition, the company has 10 varieties of antibiotic intermediates and 4 varieties of medical devices with 7 specifications. The drugs produced by the company are classified according to the scope of clinical application, with a total of 25 dosage forms and 568 kinds of drugs.

Staff size:About 20000 persons

Registered capital:RMB 1 billion 425 million

Producer:Zhuhai Rundu Mintong Pharmaceutical Co., Ltd. has been renamed Zhuhai Rundu Pharmaceutical Co., Ltd.

Staff size:About 2000 persons

Registered capital:RMB 185 million 700 thousand

Producer:Zhuhai Rundu Pharmaceutical Co., Ltd. is a modern scientific and technological pharmaceutical enterprise integrating drug R & D, production and sales. It is located in Jinwan District, Zhuhai City, Guangdong Province. It was established in 1999. On January 5, 2018, the company was listed on Shenzhen Stock Exchange

The company has a sound quality management system and has established a drug production and manufacturing center in strict accordance with the national GMP requirements. The existing product production lines (including APIs, tablets, capsules, preparation intermediates (pellets), etc.) have passed the new national GMP certification, and some characteristic API products have passed the official certification of the World Health Organization, the European Union and Japan, Some products have passed the on-site inspection of FDA.

Staff size:About 2000 persons

Registered capital:RMB 185 million 700 thousand

Producer:Chongqing Huapont Shengchem Pharm Co., Ltd.  (Hereafter called Huapont Pharm.) is a leading dermatological drug manufacturer in China. Huapont Pharm was established in 1992 by Dr Songshan Zhang, now he is a member of of Huapont Life Science Co., Ltd. which is a non-state owned public company listed in Shenzhen Stock Exchange since 2004.

With over 25 years’ development, Huapont Pharm rely on science and technology, continually provide the highly effective medicines and service to patients and society. From a leading manufacturer of dermatological drugs and gradually expand the product mix to respiratory system drugs, drugs for tumors, drugs for TB and drugs treating cardio-cerebrovascular diseases, etc. Both the finished dosage forms (FDFs) and active pharmaceutical ingredients (APIs) are manufactured and supplied to the domestic and international market. 

The API facility of Huapont Pharm has become an exporting base of APIs, where of GMP has inspected and approved by US-FDA, MEDSAFE, COFEPRIS, other countries authorities and number of customers. 

Staff size:300-399 persons

Registered capital:RMB 100 million

Producer:Yichang HEC Changjiang Pharmaceutical Co., Ltd., formerly Yichang Changjiang Pharmaceutical Co., Ltd., was restructured into a joint stock limited company in 2015.

HEC pharmaceutical is the largest manufacturer of macrolide in the world and has passed the FDA certification; It is the largest Tamiflu production base in China; It is one of the enterprises with the highest level of producing insulin biological drugs; It is the most powerful enterprise in R & D, overseas registration and production of generic drugs in Europe, America and other developed countries; It is the first domestic pharmaceutical enterprise with independent research and development, independent registration and certification by FDA, EU and who.

Staff size:About 5000 persons

Registered capital:RM 45.202285 million

Producer:Sichuan MED-SHINE Pharmaceutical Co., Ltd.is now located in the only national cross-strait science and Technology Industry Development Zone in Western China, covering an area of more than 70 mu. It is a wholly-owned subsidiary of Huabang life health Co., Ltd.

The company's products mainly involve three fields: antiviral, anti tuberculosis and immune preparations. The company has perfect quality testing equipment and quality management system. It has always emphasized scientific and standardized management, strictly implemented the drug production quality management specification (GMP), and continuously improved the software and hardware facilities to fundamentally ensure the stability and reliability of product quality.

Staff size:400-499 persons

Registered capital:RMB 50 million

The enterprise has established a quality assurance system in line with international quality supervision concepts such as ICH, FDA and EDQM. All dosage forms and varieties have passed the new national GMP certification and won the title of "the best industrial enterprise in China's pharmaceutical R & D product line" for many times. The overall quality management level ranks in the forefront of the same industry in the country.

Staff size:4000-4990 persons

Registered capital:RMB 363.908 million

Producer:The predecessor of Dandong Yichuang Pharmaceutical Co., Ltd. is the former Dandong pharmaceutical factory. The former Dandong pharmaceutical factory was founded in 1954 and is a large state-owned enterprise. Dandong Yichuang Pharmaceutical Co., Ltd. is a joint-stock company transformed on this basis in December 2003. The registered capital of the company is 7.14 million yuan and has total assets of 460 million yuan. The new plant is located in the Binhai west area of Donggang Economic Development Zone, covering an area of 131 mu with a total investment of nearly 240 million yuan. As of June 2015, it has completed the new national GMP certification of small volume injection, solid oral preparation and synthetic API workshop and obtained the certificate. The company's main product dosage forms officially reached production in 2015. The new plant has formed a production capacity of 240 tons of chemical APIs, 3 billion tablets, 50 million freeze-dried powder injections and 50 million water injections.

Staff size:200-299 persons

Registered capital:RMB 7 million 142 thousand and 857

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978